These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31920434)

  • 21. Formulating powder-device combinations for salmeterol xinafoate dry powder inhalers.
    Hassoun M; Ho S; Muddle J; Buttini F; Parry M; Hammond M; Forbes B
    Int J Pharm; 2015 Jul; 490(1-2):360-7. PubMed ID: 25987210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced Peak Inspiratory Effort through the Diskus((R)) and the Turbuhaler((R)) due to Mishandling is Common in Clinical Practice.
    Melani AS; Bracci LS; Rossi M
    Clin Drug Investig; 2005; 25(8):543-9. PubMed ID: 17532698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Real life dose emission characterization using COPD patient inhalation profiles when they inhaled using a fixed dose combination (FDC) of the medium strength Symbicort
    Bagherisadeghi G; Larhrib EH; Chrystyn H
    Int J Pharm; 2017 Apr; 522(1-2):137-146. PubMed ID: 28254655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of holding position during inhalation on drug release from a reservoir-, blister- and capsule-type dry powder inhaler.
    Kondo T; Tanigaki T; Yokoyama H; Hibino M; Tajiri S; Akazawa K; Yamada Y; Cassan SM
    J Asthma; 2017 Oct; 54(8):792-797. PubMed ID: 27929704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aerodynamic dose emission characteristics of dry powder inhalers using an Andersen Cascade Impactor with a mixing inlet: the influence of flow and volume.
    Yakubu SI; Assi KH; Chrystyn H
    Int J Pharm; 2013 Oct; 455(1-2):213-8. PubMed ID: 23892154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measurement of peak inspiratory flow with in-check dial device to simulate low-resistance (Diskus) and high-resistance (Turbohaler) dry powder inhalers in children with asthma.
    Amirav I; Newhouse MT; Mansour Y
    Pediatr Pulmonol; 2005 May; 39(5):447-51. PubMed ID: 15765541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimal Inhalation Flow Pattern from Turbuhaler Predicted by Laser Photometry.
    Kondo T; Hibino M; Tanigaki T; Tajiri S; Horiuchi S
    J Aerosol Med Pulm Drug Deliv; 2022 Jun; 35(3):139-145. PubMed ID: 34637629
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of USP Induction Ports, Glass Sampling Apparatus, and Inhaler Device Resistance on Aerodynamic Patterns of Fluticasone Propionate-Loaded Engineered Mannitol Microparticles.
    Mehta P; Bothiraja C; Kadam S; Pawar A
    AAPS PharmSciTech; 2019 May; 20(5):197. PubMed ID: 31123855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lung characteristics in elderly males and females patients with COPD: differences and optimal use of dry powder inhalers (DPIs).
    Terzano C; Oriolo F
    Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2708-2716. PubMed ID: 28678314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of dry powder inhaler resistance on the inspiratory flow rates and volumes of cystic fibrosis patients of six years and older.
    Tiddens HA; Geller DE; Challoner P; Speirs RJ; Kesser KC; Overbeek SE; Humble D; Shrewsbury SB; Standaert TA
    J Aerosol Med; 2006; 19(4):456-65. PubMed ID: 17196074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel approach for real-time monitoring of carrier-based DPIs delivery process
    Zhang X; Cui Y; Liang R; Wang G; Yue X; Zhao Z; Huang Z; Huang Y; Geng J; Pan X; Wu C
    Acta Pharm Sin B; 2020 Jul; 10(7):1331-1346. PubMed ID: 32874832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance indicators for carrier-based DPIs: Carrier surface properties for capsule filling and API properties for in vitro aerosolisation.
    Faulhammer E; Zellnitz S; Wutscher T; Stranzinger S; Zimmer A; Paudel A
    Int J Pharm; 2018 Jan; 536(1):326-335. PubMed ID: 29217472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of inhalation flow patterns of soft mist inhaler co-prescribed with dry powder inhaler using inspiratory flow meter for multi inhalation devices.
    Hira D; Koide H; Nakamura S; Okada T; Ishizeki K; Yamaguchi M; Koshiyama S; Oguma T; Ito K; Funayama S; Komase Y; Morita SY; Nishiguchi K; Nakano Y; Terada T
    PLoS One; 2018; 13(2):e0193082. PubMed ID: 29462195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inspiratory efforts achieved in use of the Technosphere insulin inhalation system.
    Smutney CC; Friedman EM; Polidoro JM; Amin N
    J Diabetes Sci Technol; 2009 Sep; 3(5):1175-82. PubMed ID: 20144434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clarifying the dilemmas about inhalation techniques for dry powder inhalers: integrating science with clinical practice.
    Azouz W; Chrystyn H
    Prim Care Respir J; 2012 Jun; 21(2):208-13. PubMed ID: 22336894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of Drug Release Dynamics of the Reservoir-type Dry Powder Inhalers.
    Tajiri S; Kondo T; Tanigaki T; Asano K; Hibino M; Horiuchi S; Kobayashi I; Nishiya K
    Tokai J Exp Clin Med; 2020 Sep; 45(3):102-107. PubMed ID: 32901895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhalation characteristics of asthma patients, COPD patients and healthy volunteers with the Spiromax® and Turbuhaler® devices: a randomised, cross-over study.
    Azouz W; Chetcuti P; Hosker H; Saralaya D; Chrystyn H
    BMC Pulm Med; 2015 May; 15():47. PubMed ID: 25927483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ease-of-use preference for the ELLIPTA® dry powder inhaler over a commonly used single-dose capsule dry powder inhaler by inhalation device-naïve Japanese volunteers aged 40 years or older.
    Komase Y; Asako A; Kobayashi A; Sharma R
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1365-75. PubMed ID: 25525354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dry-powder inhalers in patients with persistent airflow limitation: usability and preference.
    Dal Negro RW; Povero M
    Multidiscip Respir Med; 2016; 11(1):31. PubMed ID: 27597888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluating the Effectiveness of Written Dry Powder Inhaler Instructions and Health Literacy in Subjects Diagnosed With COPD.
    Alsomali HJ; Vines DL; Stein BD; Becker EA
    Respir Care; 2017 Feb; 62(2):172-178. PubMed ID: 28028187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.